Table 5.

Panel recommendations for CEL (WHO)/CEL, NOS (ICC)

DiseasePanel recommendations
CEL (WHO)/CEL, NOS (ICC) Given the poor prognosis of CEL/CEL, NOS and the risk of organ dysfunction, all patients should be considered for HCT at diagnosis with a prompt donor search
Careful assessment of cardiac and pulmonary function is advised for transplant eligibility and then for tailoring transplant platform
Given the lack of disease-modifying agents, no recommendation can be made on pretreatment strategies
Transplant should not be delayed once a suitable donor is found 
DiseasePanel recommendations
CEL (WHO)/CEL, NOS (ICC) Given the poor prognosis of CEL/CEL, NOS and the risk of organ dysfunction, all patients should be considered for HCT at diagnosis with a prompt donor search
Careful assessment of cardiac and pulmonary function is advised for transplant eligibility and then for tailoring transplant platform
Given the lack of disease-modifying agents, no recommendation can be made on pretreatment strategies
Transplant should not be delayed once a suitable donor is found 

or Create an Account

Close Modal
Close Modal